MDA Statement RE: Sarepta Therapeutics To Submit NDA for Duchenne Muscular Dystrophy Next Year

Disease: 
Link: 
Time Stamp: 
0
Thumbnail: 
http://www.assets.mda.org/pr/MDA_logo_FMD.jpg
Node Type: 
Quest News